HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

US False COVID-19 Claims Continue Climbing Along With Rate Of Virus’ Spread Globally

Executive Summary

FTC nearly doubles its total of warnings on false and misleading COVID-19 claims for consumer health products with 50 announced on 21 May. WHO reported the same day that the largest number of COVID-19 cases, more than 106,000, were recorded in any 24-hour period during the pandemic.

You may also be interested in...



Superfood Firm Calls Immunity Claim Ordinary, But Doesn’t Contest COVID-19 Inquiry

The firm immediately discontinued social media video conveying an implied message that using its Immunity Bundle protects against contracting COVID-19 after BBB National Programs requested evidence supporting the claim.

False COVID-19 Claims In US Consumer Health Market: Rampant With Forecast For More

In addition to 45 businesses with varying levels of communication skills the FTC targeted in its latest batch of warnings about false advertising linked coronavirus, the FDA "sent hundreds of abuse complaints to domain name registrars and internet marketplaces" also linked to bogus COVID-19 claims.

Patch, Soap and Essential Oil Firms Warned On COVID-19 Claims, Court Silences Herbal Firm

FDA and FTC submit another three warnings to consumer health marketers making bogus claims to prevent or treat COVID-19. FTC also announces California firm agreed to court order to stop claiming a supplement consisting mainly of vitamin C and herbal extracts is an effective treatment.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS150053

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel